|
VOLUME 33: NO. 5 MAY 2006
Editorials
Anti-Tumor Necrosis Factor-a Agents for Rheumatoid Arthritis: Assessing Longterm Safety
 K.L. Hyrich, A.J. Silman.........831
Quantitative Clinical Rheumatology The DAS Is the Most Specific Measure, But a Patient Questionnaire
Is the Most Informative Measure to Assess Rheumatoid Arthritis
 T. Pincus.........834
Identifying Those at Risk of Developing Persistent Pain Following a Motor Vehicle Collision
 M. Sterling.........838
Classification in Systemic Sclerosis
 S.R. Johnson, R.M. Laxer.........840
Articles
Role of SLC22A4, SLC22A5, and RUNX1 Genes in RA
 A. Martínez, A. Valdivia, D. Pascual-Salcedo, et al.........842
A Phase I Study Assessing the Safety, Clinical Response, and Pharmacokinetics of an Experimental Infliximab Formulation for Subcutaneous or Intramuscular Administration in Patients with RA
 R. Westhovens, F. Houssiau, J. Joly, et al .........847
Etanercept Treatment in Adults with Established RA: 7 Years of Clinical Experience
 L.W. Moreland,
M.E. Weinblatt, E.C. Keystone, et al.........854
Controlled Trial of MTX versus CH-1504 in the Treatment of RA
 O. Castaneda, M.G. Nair.........862
Safety of Infliximab Used in Combination with Leflunomide or Azathioprine in Daily Clinical Practice
 A. Perdriger, X. Mariette, J-L. Kuntz, et al .........865
Patient's Ethnicity Does Not Influence Utilization of Effective Therapies in RA
 D.C. Ang, H.E. Paulus, J.S. Louie.........870
Functional Health Literacy of Patients with RA Attending a Community-Based Rheumatology Practice
 R. Buchbinder, S. Hall, J.M. Youd.........879
Parvovirus B19 Infection in Patients with RA in Taiwan
 Y-S. Chen, P-H. Chou, S-N. Li, et al .........887
Survival Analysis and Longterm Results of Elbow Synovectomy in RA
 M. Fuerst, B. Fink, W. Rüther.........892
Laboratory and Imaging Studies Used by
French Rheumatologists to Evaluate Patients
with Early Arthritis
 A. Saraux, B. Fautrel, J.F. Maillefert, et al .........897
Role of Endothelial Damage in the Pathogenesis of Interstitial Pneumonitis in Patients with PM and DM
 M. Funauchi, H. Shimadsu, C. Tamaki, et al.........903
Validity of Screening Tests for SS in Ambulatory Patients with Chronic Diseases
 J. Sánchez-Guerrero,
M.R. Pérez-Dosal, E. Celis-Aguilar, et al.........907
Cepharanthin, a Biscoclaurine Alkaloid, Prevents Destruction of Acinar Tissues in Murine SS
 M. Azuma, Y. Ashida, T. Tamatani, et al.........912
Effects of Infliximab Treatment on Lipoprotein
Profile in Patients with RA and AS
 D.N. Kiortsis,
A.K. Mavridis, T.D. Filippatos, S. Vasakos,
S.N. Nikas, A.A. Drosos.........921
Patients with PsA Have an Increased Number of Lymphocytes in the Duodenal Mucosa in
Comparison with Patients with Psoriasis Vulgaris
 U. Lindqvist, G. Kristjánsson, I. Pihl-Lundin,
E. Hagforsen, G. Michaëlsson.........924
Characterization of an Activation Factor Released from Human Neutrophils After Stimulation by
Triclinic MSU Crystals
 P. Desaulniers, S. Marois,
G. Paré, O. Popa-Nita, C. Gilbert, P.H. Naccache .........928
Ambulatory Physical Activity, Disease Severity,
and Employment Status in Adult Women with
OA of the Hip
 S. Hirata, R. Ono, M. Yamada, et al.........939
Longterm Effects of Intraarticular Hyaluronan on Synovial Fluid in OA of the Knee
 H. Bagga, D. Burkhardt, P. Sambrook, L. March.........946
A Prospective, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy of Intraarticular Hyaluronic Acid for OA of the Knee
 R.J. Petrella, M. Petrella.........951
Medicinal and Injection Therapies for Mechanical Neck Disorders: A Cochrane Systematic Review
 P.M. Peloso, A.R. Gross, T.A. Haines, et al.........957
Predicting New Onset of Widespread Pain
Following a Motor Vehicle Collision
 G. Wynne-Jones, G.T. Jones, N.J. Wiles,
A.J. Silman, G.J. Macfarlane .........968
Alberta Rodeo Athletes Do Not Develop the
Chronic Whiplash Syndrome
 A.L. Shannon, R. Ferrari, A.S. Russell.........975
Meeting Report Summary of the 2005 Annual Research and Education Meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN)
 M.M. Ward, J. Bruckel, R. Colbert, et al.........978
Meeting Report Panamerican Congress of Spondyloarthropathies, Cartagena, Colombia, October 20-22, 2005: Latin American Rheumatology Comes of Age!
 R. Valle, D. Yu, L.R. Espinoza.........983
Pediatric Rheumatology
Evaluation of the Comparative Efficacy and Tolerability of Rofecoxib and Naproxen in Children and Adolescents with JRA: A 12-Week Randomized Controlled Clinical Trial with a 52-Week Open-Label Extension
 A. Reiff, D.J. Lovell, J. van Adelsberg, et al .........985
Clinical Significance of Decreased Serum Concentration of Cartilage Oligomeric Matrix
Protein in Systemic JIA
 T. Urakami, A. Manki,
T. Inoue, M. Oda, H. Tanaka, T. Morishima.........996
BMD and Turnover in Non-Corticosteroid Treated African American Children with JRA
 A.J. Head, L.K. Myers, M.A. Watsky, et al.........1001
Childhood Onset SSc: Classification, Clinical and Serologic Features, and Survival in Comparison with Adult Onset Disease
 K. Scalapino, T. Arkachaisri, M. Lucas, et al.........1004
TNF-a Inhibition and VATER Association:
A Causal Relationship?
 J.D. Carter, J. Valeriano, F.B. Vasey.........1014
Case Reports
Neurological Complications of Infliximab
 J. Jarand, D.W. Zochodne, L.O. Martin, C. Voll .........1018
Rituximab as Therapy for Refractory PM and DM
 E.H. Noss, D.L. Hausner-Sypek, M.E. Weinblatt.........1021
Letters
Association of RA with Multiple Sclerosis: Report of 14 Cases and Discussion of Its Significance
E. Toussirot, E. Pertuiset, A. Martin, et al .........1027
Regulation of Killer Immunoglobulin-like Receptors
in SLE
T. Momot, R.E. Schmidt, T. Witte.........1029
Angry Fat
D.L. Jardine, J. Gardner, R. Steele.........1030
Meetings in Rheumatology
|